Last reviewed · How we verify
Intravenous ketorolac and oral acetaminophen
Intravenous ketorolac and oral acetaminophen is a Small molecule drug developed by University of Puerto Rico. It is currently FDA-approved.
Intravenous ketorolac and oral acetaminophen, marketed by the University of Puerto Rico, is a combination therapy currently available in the pain management market. The key composition patent is set to expire in 2028, providing a period of exclusivity that supports market stability. The primary risk is the lack of reported key trial results and revenue data, which may limit investor confidence and market competitiveness.
At a glance
| Generic name | Intravenous ketorolac and oral acetaminophen |
|---|---|
| Sponsor | University of Puerto Rico |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Opioid Sparing Effect of an ISP Nerve Block on Post-Op Pain Control in Posterior Cervical Spine Surgery (NA)
- Postoperative Pain Management in Patients Undergoing Intramedullary Nail Fixation After Tibia and Femoral Fractures (PHASE4)
- ICE-T Pain Regimen for Total Laparoscopic Hysterectomy (PHASE4)
- An Evaluation of Pain Outcomes of Ketorolac Administration in Children Undergoing Circumcision (PHASE2)
- Randomized Study Comparing the Use of Epidural Analgesia to Intravenous Narcotics for Laparoscopic Colorectal Resection. (NA)
- Post-op Acetaminophen vs NSAID Use on Lumbar Spinal Fusion Outcomes (NA)
- Steroids in Total Knee Arthroplasty (PHASE4)
- Efficacy of NSAID and Acetaminophen in the Control of Post-Operative Pain in Patients Undergoing Total Knee Replacement (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Intravenous ketorolac and oral acetaminophen CI brief — competitive landscape report
- Intravenous ketorolac and oral acetaminophen updates RSS · CI watch RSS
- University of Puerto Rico portfolio CI